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IN previous carcinogenicity tests on newborn BALB/c mice, ethyl methane
sulphonate was found to be weakly active but the results for 2-naphthylamine and
2-naphthylhydroxylamine were equivocal (Roe, Mitchley and Walters, 1963).
Allthree compounds arecarcinogenicinadultmice (Connell, 1961; Bonser, Clayson,
Jull and Pyrah, 1952; Bonser, Boyland, Busby, Clayson, Grover and Jull, 1963).
Pietra and his colleagues (Pietra, Spencer and Shubik, 1959; Pietra, Rappaport
and Shubik, 1961) first demonstrated that newborn mice were susceptible to very
small doses of chemical carcinogens, including both polycyclic hydrocarbons and
urethane. Roe, Rowson and Salaman (1961) suggested that neonatal injection
might be a sensitive technique for testing potential carcinogens. Since the results
of the first tests of carcinogens other than polycyclic hydrocarbons, or urethane,
were inconclusive (Roe et al., 1963), the experiments were repeated using higher
doses, different vehicles and repeated injections. In addition, 2-acetylamino-
fluorene was tested.
MATERIALS AND METHODS
Mice.-BALB/c (Bittner agent-free) and C57B1 mice were of lines maintained
in the Institute by brother-sister mating since 1952. BALB/c mice were originally
obtained from Dr. H. B. Andervont of the National Cancer Institute, National
Institute of Health, United States Public Health Service, and C57B1 from the
University ofMinnesota. The mice were housed in metal cages and given a cubed
diet (Diet 86, Messrs. Dixon and Sons, Ware, Herts.) and water ad libitum. During
the experiments the mice were inspected daily and examined thoroughly once
each week. They were weaned and the sexes were separated when they were
about four weeks old. As a precaution against ectromelia the mice were vacci-
nated with sheep lymph. Sick mice were killed. All mice which were killed or
which died during an experiment, or were killed at the end ofan experiment, were
examined post-mortem. Lung adenomas were counted and fixed for microscopic
confirmation. Other lesions which were possibly neoplastic were also taken for
histological section.
Chemical agents.-2-Naphthylamine was obtained from British Drug Houses;
and 2-acetylaminofluorene from Light and Co. Ltd. 2-Naphthylhydroxylamine
was prepared in the Institute by Dr. P. L. Grover; and ethyl methane sulphonate
(CB 1528) by Prof. W. C. J. Ross.368 MARGARET A. WALTERS, F. J. C. ROE, B. C. V. MITCHLEY AND A. WALSH
Experiment I
Fifty-two litters of BALB/c mice were randomly divided into ten groups of
between 50 and 60 animals. The mice were injected subcutaneously, either once
during the first 24 hours after birth, or once daily on the first five days of life.
Group 1 received one injection of 100,ug. 2-naphthylamine; Group2,five injections
each of 100,tg. 2-naphthylamine; Group 3, one injection of 100,ug. 2-naphthyl-
hydroxylamine; Group 4, five injectionseachof100,ug. 2-naphthylhydroxylamine;
Group 5, one injection of 100,ug. 2-acetylaminofluorene; Group 6, five injections
each of 100,tg. 2-acetylaminofluorene; Group 7, one injection of 200,g. ethyl
methane sulphonate; Group 8, five injections each of 200,g. ethyl methane
sulphonate. All doses were given in 0X02 ml. arachis oil. Group 9 received one
injection of 0X02 ml. arachis oil and Group 10, five injections of arachis oil.
Surviving mice were killed after 40 weeks. The incidence of lung adenomas
in the survivors is shown in Table I. No other tumours were observed. Neither
one nor five injections of 2-naphthylamine or ofethyl methane sulphonate yielded
a significantly greater incidence of lung tumours than that in the respective
control groups. The lung tumour incidence was significantly higher than the
control level when the mice received five injections of 2-naphthylhydroxylamine
(P < 0.05) and 2-acetylaminofluorene (P < 0'02). The mean number oftumours
per survivor was also significantly greater in these two groups (P < 0-01) and in
the group which had only one injection of 2-naphthylhydroxylamine (P < 0.01).
Experiment 2
Thirty-two litters of BALB/c mice were randomly divided into four groups.
All of the mice were injected subcutaneously once daily on each of the first five
days of life. Group 1 received five injections of 100jIg. 2-naphthylamine;
Group 2, five injections of 100,ig. 2-naphthylhydroxylamine; and Group 3, five
injections of 200,Ig. ethyl methane sulphonate. The compounds were suspended
in 0*02 ml. 3% aqueous gelatine. Group 4 received five injections of aqueous
gelatine.
The survivors were killed at 50 weeks of age. Table IJ shows the incidence of
pulmonary adenomas. No other tumours were seen. 2-naphthylhydroxylamine
and ethyl methane sulphonate induced a significantlyhigher incidence (P < 0 001)
and multiplicity (P < 0.01 and P < 0-05, respectively) oflung tumours than that
in the control group. Both incidence and multiplicity of lung adenomas were
greater in 2-naphthylamine-treated mice than in the controls, but the difference
was not significant.
Experiment 3
Two groups of between 50 and 60 C57B1 mice were composed om 19 randomly
distributed litters. The mice were injected once daily for the first five days oflife.
Group 1 received five injections of 200jug. ethyl methane sulphonate in 0*02 ml.
arachis oil, and Group 2 were given five injections of arachis oil only. The
survivors were killed between the 55th and 60th weeks of the experiment. No
tumours developed in control animals. The lung tumour incidence in the ethyl
methane sulphonate-treated mice is shown in Table II.
One mouse, which died at 23 weeks, had a malignant lymphoma.369 CARCINOGENESIS STUDIES ON NEWBORN MICE
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DISCUSSION
Five injections of 200,g. ethyl methane sulphonate induced lung tumours
in all surviving BALB/c mice when aqueous gelatine was the vehicle: but in only
15X7% of the animals (not significantly more than in the controls) when arachis
oil was used. The group which received ethyl methane sulphonate in aqueous
gelatine was killed at 50 weeks and the arachis oil group at 40 weeks. It is not
thought that this difference accounted for the difference in result. A more likely
explanation is that material injected in arachis oil remains longer at the site of
injection and does not as readily reach the lungs during the early neonatal period.
Carcinogens suspended in aqueous gelatine induced tumours at many sites of the
body when injected into newborn mice (Pietra et at., 1961; Roe et al., 1961).
This suggests that the carcinogens spread throughout the body. The same dose
of ethyl methane sulphonate in arachis oil did however induce lung tumours in
significantly more C57B1 mice than in the controls, in which there were none.
The incidence of pulmonary adenomas was low in the treated group but C57B1
is known to be a strain resistant to the induction oflung tumours (Shimkin, 1940).
Repeated injections of 2-naphthylhydroxylamine, given in arachis oil or
aqueous gelatine, induced a greater incidence and multiplicity of lung tumours in
surviving mice than in the controls. A single injection of the compound at birth
increased the mean number of tumours per mouse above the control level. That
the activity of 2-naphthylhydroxylamine was markedly greater than that of the
parent amine, 2-naphthylamine, is in agreement with the theory that the aromatic
amines such as 2-naphthylamine are converted to active proximate carcinogens
by metabolic processes. Clayson (1953) suggested that the aromatic amines were
carcinogenic because of their conversion to ortho-hydroxylamines. Some of these
compounds were shown to be carcinogenic by the technique of bladder pellet
implantation in mice (Bonser, Bradshaw, Clayson and Jull, 1956), but 2-naphthyl-
hydroxylamine, a metabolite formed by N-hydroxylation (Boyland, Manson and
Nery, 1960), has induced a higher incidence of bladder tumours than any other
compound tested (Bonser et al., 1963). More than halfof 66 mice implanted with
pellets of 2-naphthylhydroxylamine mixed with stearic acid developed bladder
tumours. None were found in a group of 74 mice implanted with 2-naphthyl-
amine/stearic acid pellets. Intraperitoneal injections of 2-naphthylhydroxyl-
amine induced abdominal tumours in nine out of fifteen rats, while only two of
fourteen rats developed sarcomas following similar treatment with 2-naphthyl-
amine (Boyland, Dukes and Grover, 1963).
It is possible that the failure of 2-naphthylamine to induce tumours when
injected into mice during the first week of life is due to the immaturity of the
microsomal enzymes which carry out N-hydroxylation. Jondorf, Maickel and
Brodie (1958) found that newborn mice and guinea-pigs are deficient in certain
drug-metabolising enzymes in liver microsomes. Enzyme systems for meta-
bolising amidopyrine, phenacetin and hexobarbitone were absent 24 hours after
birth. The mechanisms appeared during the first week and increased in activity
until the animals were about eight weeks old.
2-Acetylaminofluorene, another aromatic amine, yielded significantly more
lung tumours than seen in control mice, when five doses were given to newborn
mice. It is also a more potent carcinogen for the adult mouse than 2-naphthyl-
amine (Hartwell, 1951; Shubik and Hartwell, 1957), inducing tumours of the
liver, kidney, bladder, thyroid and breast.CARCINOGENESIS STUDIES ON NEWBORN MICE
Newborn mice have been shown to be susceptible to the action of dimethyl-
nitrosamine (Toth, Magee and Shubik, 1964), 4-nitroquinoline (Kimura and
Senra, 1964), o-aminoazotoluene (Nishizuka, Ito and Nakakuki, 1965) and ethyl
methane sulphonate, as well as to polycyclic hydrocarbons and urethane (Pietra
et al., 1961). They respond, therefore, to carcinogens of several different types.
However, if compounds such as 2-naphthylamine give negative results, the
technique of injecting newborn animals is not suitable for screening for carcino-
genicity. Tests in newborn mice in parallel with tests in adults might be useful.
Newborn mice appear to be more sensitive than adults to some compounds, for
example, 1,2-benzanthracene (Roe et al., 1963), and they are susceptible to very
small doses (O'Gara, Kelly, Brown and Mantel, 1965; Walters, 1966).
These experiments show that response to neonatally-injected carcinogens
varies with the strain of mouse and with the solvent or suspending medium.
Five injections, once daily for the first five days of life were more effective in
inducing lung tumours than a single injection given within 24 hours of birth.
SUMMARY
1. Test compounds were injected subcutaneously into mice, either once during
the first 24 hours after birth or once daily during the first five days oflife.
2. Five injections of 200,ug. ethyl methane sulphonate in 3% aqueous gelatine
induced lung adenomas in all surviving BALB/c mice at 50 weeks. The mean
number of tumours per mouse was significantly greater than in control mice.
The same dose of ethyl methane sulphonate dissolved in arachis oil increased the
incidence of lung tumours significantly in C57B1, but not in BALB/c mice.
3. 2-Acetylaminofluorene gave a positive result when the BALB/c mice
received five injections of 100 ug. in arachis oil, but the response to a single
injection was negative.
4. The incidence ofpulmonary adenomas in BALB/c mice given five injections
of 100,ug. 2-naphthylamine in aqueous gelatine was slightly, but not significantly,
higher than that in the control group. 2-Naphthylamine injected in arachis oil
was inactive.
5. Five injections of 100,ug. 2-naphthylhydroxylamine, in either aqueous
gelatine or arachis oil, significantly increased both the incidence and the multi-
plicity of lung tumours above the control level in BALB/c mice. The tumour
incidence was slightly increased by a single injection of 2-naphthylhydroxylamine
and the mean number of tumours per mouse was significantly greater than the
control.
6. The superior carcinogenic potency of2-naphthylhydroxylamine over that of
2-naphthylamine in this test system supports the view that N-hydroxylation is
involved in the carcinogenicity of certain aromatic amines.
7. The results indicate that aqueous gelatine is superior to arachis oil as a
vehicle in this type of test and that positive results are more likely to be obtained
with five injections than with one injection ofthe test material.
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